Sorry, but no relevant information or results could be found for your search.
Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable
Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could cut development time from twelve years to seven or eight and double the success rate from 8 to 16 percent.<br /> The article Anthropic launches its own drug discovery programs to tackle diseases Big Pharma consider [...]
Nebius raised $775 million by borrowing against its GPUs. It has $40 billion more contracts to securitise.
Nebius raised $775 million in its first secured debt facility, borrowing against deployed GPU infrastructure and contracted cash flows from an investment-grade customer. The facility matures on October 31, 2030, and is priced at SOFR + 2.50%, roughly 6.8% at current rates. Together with the customer agreement’s cash flows, the facility covers more than 100% […]<br /> This story continues [...]
